Bevacizumab With Abraxane in Patients With Recurrent Ovarian/ Peritoneal Cancer

Part of paid clinical trials in Little Rock, Arkansas.

Sponsor
Accelerated Community Oncology Research Network
Study ID
NCT00407563
Phase
PHASE2
Status
Completed

Conditions

Eligibility Criteria

Sex
FEMALE
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Bevacizumab — DRUG
    Bevacizumab will be given via IV infusion at 10mg/kg given on days 1 and 15 of a 28-day cycle.
  • Abraxane — DRUG
    Abraxane will be given via IV infusion at 100mg/m²over 30 minutes on days 1, 8, and 15 of a 28-day cycle.

Study Details

The purpose of this study is to evaluate the effectiveness and tolerability of the combination of bevacizumab and Abraxane in the treatment of women with epithelial ovarian cancer or peritoneal cancer. The study will also evaluate how the patient's quality of life is during their treatment.

Key Dates

First listed
Dec 5, 2006
Start date
Jan 31, 2007
Status verified
Mar 2012
Primary completion
Feb 28, 2011
Completion
Feb 28, 2011

Study Design

Enrollment
48 participants (actual)
Allocation
NON_RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT

Primary Outcome Measure

6-month Progression-Free Rate [ Time Frame: 6 months after initiation of study treatment ]

Locations (11)

FacilityCityStateZIPSite coordinators
Little Rock Hematology OncologyLittle RockArkansas72205-
Wilshire Oncology Medical Group, Inc.La VerneCalifornia91750-
Northeast Georgia Cancer Care, LLCAthensGeorgia30607-
Southeastern Gynecologic Oncology, LLCAtlantaGeorgia30342-
North Idaho Cancer CenterCoeur d'AleneIdaho38314-
Hematology-Oncology Centers of the Northern RockiesBillingsMontana59101-
Mid-Ohio Oncology/HematologyColumbusOhio43219-
Pennsylvania Oncology Hematology Assoc.PhiladelphiaPennsylvania19106-
Chattanooga's Program in Women's OncologyChattanoogaTennessee37403-
The West ClinicMemphisTennessee38120-
Cancer Specialists of Tidewater, LtdChesapeakeVirginia23320-

Find similar trials in Little Rock, AR

By condition
Ovarian cancer
By specialty
OncologyGynecologic oncologyWomen's health
By research site
Little Rock Hematology Oncology· Little Rock, ARWilshire Oncology Medical Group, Inc.· La Verne, CANortheast Georgia Cancer Care, LLC· Athens, GASoutheastern Gynecologic Oncology, LLC· Atlanta, GANorth Idaho Cancer Center· Coeur d'Alene, IDHematology-Oncology Centers of the Northern Rockies· Billings, MT

Related Studies